Daniel Gallo
Directeur Technique/Scientifique/R&D chez ZEVRA THERAPEUTICS, INC.
Profil
Daniel Gallo is the founder of Jaguar Gene Therapy LLC.
He is currently working as the Senior Vice President-Medical Affairs & Advocacy at Zevra Therapeutics, Inc. since 2023.
Previously, he worked as the Vice President at Orphazyme A.
Dr. Gallo obtained a doctorate degree from Northwestern University.
Postes actifs de Daniel Gallo
| Sociétés | Poste | Début |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/01/2023 |
Anciens postes connus de Daniel Gallo
| Sociétés | Poste | Fin |
|---|---|---|
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Fondateur | - |
Formation de Daniel Gallo
| Northwestern University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| Entreprise privées | 1 |
|---|---|
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Health Services |
